Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d40a1b4abdc71ad6961afb587275cf7 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
filingDate |
2004-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69fc1a01dba29726dbb522cb2bb7ecf4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3688bfad3d724ac7c057b3cc324532cf |
publicationDate |
2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005085464-A1 |
titleOfInvention |
Composition of anti-HIV drugs and anti-cortisol compounds and method for decreasing the side effects of anti-HIV drugs in a human |
abstract |
The present invention is based, in part, upon the discovery that the use of an anti-HIV drug in combination with at least one cortisol blocker such as procaine, reduces the side effects associated with anti-HIV drugs. The invention also relates to a method of treating the high cortisol catabolic effects of diseases such as AIDS in the HIV positive population and those with AIDS related complexes by the administration of a cortisol blocker. The present invention also discloses a composition comprising an anti-HIV drug and cortisol blocker. More specifically, the present invention relates to a cortisol blocking composition which comprises procaine, ascorbic acid and zinc heptahydrate. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2009267016-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011166115-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11576907-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11103514-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464764-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008091704-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008091704-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008287429-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010002901-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010101413-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648245-B2 |
priorityDate |
1999-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |